Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.

Orenstein H, Raskind MA.

J Clin Psychiatry. 2010 Jan;71(1):89-91. doi: 10.4088/JCP.09l05016blu. No abstract available.

PMID:
20129010
2.

Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

Ferguson JM, Khan A, Mangano R, Entsuah R, Tzanis E.

J Clin Psychiatry. 2007 Jan;68(1):58-68.

PMID:
17284131
3.

Venlafaxine treatment of panic disorder: a case series.

Geracioti TD Jr.

J Clin Psychiatry. 1995 Sep;56(9):408-10.

PMID:
7665539
4.

Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.

Bradwejn J, Ahokas A, Stein DJ, Salinas E, Emilien G, Whitaker T.

Br J Psychiatry. 2005 Oct;187:352-9.

5.

Two cases of panic disorder responsive to low-dose sertraline.

Orenstein H.

Clin Neuropharmacol. 2010 Jul;33(4):215-6. doi: 10.1097/WNF.0b013e3181e1612e. No abstract available.

PMID:
20661029
6.

A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.

Liebowitz MR, Asnis G, Mangano R, Tzanis E.

J Clin Psychiatry. 2009 Apr;70(4):550-61. Epub 2009 Apr 7.

PMID:
19358784
7.

Low-dose venlafaxine treatment in panic disorder.

Papp LA, Sinha SS, Martinez JM, Coplan JD, Amchin J, Gorman JM.

Psychopharmacol Bull. 1998;34(2):207-9.

PMID:
9641002
8.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
9.

Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.

Møller LR, Østergaard JR.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):197-201. doi: 10.1089/cap.2008.036.

PMID:
19364297
10.

Venlafaxine-induced excessive yawning.

Chen CH, Lu ML.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):156-7. doi: 10.1016/j.pnpbp.2008.10.014. Epub 2008 Oct 31. No abstract available.

PMID:
19000733
11.
12.
13.

Use of venlafaxine in other psychiatric disorders.

Ninan PT.

Depress Anxiety. 2000;12 Suppl 1:90-4. Review.

PMID:
11098421
14.

Reduced testosterone level in a venlafaxine treated patient.

Bell S, Shipman M.

Ann Clin Psychiatry. 2000 Sep;12(3):171-3.

PMID:
10984008
15.

Use of bupropion with SRIs and venlafaxine.

Spier SA.

Depress Anxiety. 1998;7(2):73-5.

PMID:
9614595
16.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
17.

Treatment of obsessive-compulsive disorder with venlafaxine.

Grossman R, Hollander E.

Am J Psychiatry. 1996 Apr;153(4):576-7. No abstract available.

PMID:
8599411
18.
19.

Medication-associated somnambulism.

Lange CL.

J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):211-2. No abstract available.

PMID:
15725964
20.

Serotonin syndrome secondary to phenelzine-venlafaxine interaction.

Weiner LA, Smythe M, Cisek J.

Pharmacotherapy. 1998 Mar-Apr;18(2):399-403.

PMID:
9545162

Supplemental Content

Support Center